Born in an industry that can't afford to guess the plan.

Where this started

Pharmaceutical project environments run on strict regulatory redundancy. Validation steps, documentation trails, phase gates, sign-offs that have to exist before the next step is even allowed to start — none of it optional, all of it there because the cost of skipping a step isn't a missed deadline, it's a compliance failure. In that setting, a waterfall-style methodology isn't a preference. It's close to mandatory: you cannot "figure it out as you go" the way an agile team iterating on a product can, because half of what you'd normally discover mid-sprint has to be pre-approved, traceable, and reproducible before you're allowed to touch it.

And in that setting, the same failure kept repeating across projects — not execution slipping, but the plan itself being incomplete. A validation sub-step nobody flagged at kickoff. A documentation dependency that only surfaced once the team was already three steps past where it should have been raised. Because waterfall can't self-correct mid-flight the way an agile sprint can, a gap like that doesn't get caught and folded back in cheaply — it surfaces late, after real work has already been built on top of it, at exactly the point where it's most expensive and most disruptive to absorb.

The number one cause of waterfall project failure usually isn't poor execution. It's poor scoping — not knowing, from the start, everything the project will actually require to reach its objective.

A work breakdown that remembers

Klonn.it's answer to that came directly out of this experience: a standardized work breakdown structure that isn't authored once by one team and then frozen into a template. It's living — every project run through it adds to it, refines a workpackage that turned out incomplete, catches an edge case the previous project's plan missed. The next project doesn't start scoping from a blank page. It starts from the accumulated, battle-tested memory of every project that came before it.

That's where the real gain comes from — not a nicer Gantt chart, but a genuinely more complete plan on day one. Scoping goes faster because the catalog already has most of the answer, and it's more accurate because it reflects everything the organization has already learned the hard way, instead of resetting to one team's best guess at every kickoff.

Beyond pharma

Pharma isn't unique in this — it's just where the pattern was impossible to ignore. Any domain where regulation, safety, or physical consequence make redundancy and traceability non-negotiable has exactly the same failure mode, for exactly the same reason: waterfall is effectively required, and a missed scoping item surfaces late and expensive rather than getting caught mid-iteration.

The common thread isn't the industry. It's a project environment where the plan has to be right before you start, not something you're allowed to discover as you go. That's the discipline Klonn.it standardizes — one living WBS, getting more complete every time it's used, so the next project's scope is never starting from zero.